Patent Number: 8,815,534

Title: Method for assessing the efficacy of a TR1 cell therapy in a subject

Abstract: A method for assessing whether a patient subjected to an antigen-specific Tr1 cell therapy is responding to the treatment, includes: determining in vitro the antigen-specific proliferation of T cells contained in a cell sample from the patient; and comparing the antigen-specific proliferation to a standard reference, thereby determining whether the patient is responding or not to the treatment.

Inventors: Foussat; Arnaud (Biot, FR), Quatannens; Brigitte (Mandelieu-la-Napoule, FR)

Assignee: TxCell

International Classification: C12Q 1/02 (20060101); C12N 5/071 (20100101); C12N 5/00 (20060101)

Expiration Date: 8/26/12018